Bridgeway Capital Management’s Exagen XGN Stock Holding History

Bridgeway Capital Management’s Portfolio XGN Stock Details XGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$140K	Sell	30,002 -57,400	-66%	-$216K	﹤0.01%	1113
2026 Q1	$262K	Buy	87,402 +10,202	+13%	+$39.5K	0.01%	968
2025 Q4	$469K	Buy	77,200 +49,400	+178%	+$450K	0.01%	833
2025 Q3	$306K	Hold	27,800	–	–	0.01%	922
2025 Q2	$194K	Buy	27,800 +2,600	+10%	+$15.8K	﹤0.01%	967
2025 Q1	$90.5K	Buy	25,200 +4,500	+22%	+$17K	﹤0.01%	1055
2024 Q4	$84.9K	Sell	20,700 -1,100	-5%	-$3.96K	﹤0.01%	1129
2024 Q3	$67.4K	Hold	21,800	–	–	﹤0.01%	1196
2024 Q2	$39.7K	Sell	21,800 -19,000	-47%	-$32.2K	﹤0.01%	1236
2024 Q1	$64.9K	Hold	40,800	–	–	﹤0.01%	1250
2023 Q4	$81.2K	Hold	40,800	–	–	﹤0.01%	1271
2023 Q3	$100K	Sell	40,800 -6,500	-14%	-$16.5K	﹤0.01%	1233
2023 Q2	$137K	Hold	47,300	–	–	﹤0.01%	1207
2023 Q1	$115K	Hold	47,300	–	–	﹤0.01%	1208
2022 Q4	$114K	Hold	47,300	–	–	﹤0.01%	1199
2022 Q3	$128K	Hold	47,300	–	–	﹤0.01%	1227
2022 Q2	$272K	Sell	47,300 -27,700	-37%	-$161K	0.01%	1016
2022 Q1	$602K	Sell	75,000 -12,000	-14%	-$103K	0.01%	893
2021 Q4	$1.01M	Hold	87,000	–	–	0.02%	788
2021 Q3	$1.18M	Buy	87,000 +9,500	+12%	+$126K	0.02%	768
2021 Q2	$1.16M	Buy	77,500 +2,500	+3%	+$38.3K	0.02%	809
2021 Q1	$1.31M	Buy	75,000 +1,800	+2%	+$32.1K	0.02%	771
2020 Q4	$966K	Hold	73,200	–	–	0.02%	755
2020 Q3	$793K	Buy	+73,200	New	+$943K	0.02%	746

Other funds holding XGN

Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return

NCNMGF

Nano-Cap New Millennium Growth Fund Staten Island, New York $130M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

FCM

FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

MBAM

Mink Brook Asset Management West Palm Beach, Florida $227M AUM 64.76% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Bridgeway Capital Management's XGN Position: Q2 2026 in Review

Bridgeway Capital Management reduced its Exagen (XGN) stake by 66% in Q2 2026, selling an estimated $216K and leaving 30,002 shares worth $140K. The position accounts for ﹤0.01% of the portfolio, ranked #1113.

Bridgeway Capital Management first reported a position in XGN in Q3 2020 and has held it in 24 quarters since. The position peaked at $1.31M in Q1 2021. 57 funds tracked by Wall St. Rank hold XGN as of Q2 2026.

Bridgeway Capital Management held 30,002 shares of Exagen worth $140K as of Q2 2026.
Bridgeway Capital Management sold 57,400 Exagen shares in Q2 2026, an estimated $216K.
Exagen made up ﹤0.01% of Bridgeway Capital Management's portfolio in Q2 2026, its #1113 holding.
Bridgeway Capital Management first reported a position in Exagen in Q3 2020 and has held it in 24 quarters since.
Bridgeway Capital Management's Exagen position peaked at $1.31M in Q1 2021.
57 funds tracked by Wall St. Rank held Exagen as of Q2 2026.

Based on Bridgeway Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.